Literatur
-
1
Mehlhorn U, Kroner A, de Vivie E R.
30 years clinical intra-aortic balloon pumping: facts and figures.
Thorac Cardiovasc Surg.
1999;
47
298-303
-
2
Sanborn T A, Sleeper L A, Bates E R. et al .
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?.
J Am Coll Cardiol.
2000;
36
1123-1129
-
3
Wampler R K, Frazier O H, Lansing A M. et al .
Treatment of cardiogenic shock with the Hemopump left ventricular assist device.
Ann Thorac Surg.
1991;
52
506-513
-
4
Scholz K H, Dubois-Rande J L, Urban P. et al .
Clinical experience with the percutaneous hemopump during high-risk coronary angioplasty.
Am J Cardiol.
1998;
82
1107-1110
-
5
Reedy J E, Swartz M T, Raithel S C, Szukalski E A, Pennington D G.
Mechanical cardiopulmonary support for refractory cardiogenic shock.
Heart Lung.
1990;
19
514-523
-
6
Kern M J, Aguirre F V, Caracciolo E A. et al .
Hemodynamic effects of new intra-aortic balloon counterpulsation timing methods in patients: a multicenter evaluation.
Am Heart J.
1999;
137
1129-1136
-
7
Nanas J N, Moulopoulos S D.
Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects.
Cardiology..
1994;
84
156-167
-
8
Christenson J T, Cohen M.
Preoperative IABP in high-risk patients reduces postoperative lactate release and subsequent mortality.
Ann Thorac Surg.
2002;
73
1026-1027
-
9
Ferguson J J 3rd, Cohen M, Freedman R J Jr. et al .
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry.
J Am Coll Cardiol.
2001;
38
1456-1462
-
10
Kumbasar S D, Semiz E, Sancaktar O, Yalcinkaya S, Deger N.
Mechanical complications of intra-aortic balloon counterpulsation.
Int J Cardiol.
1999;
70
69-73
-
11
Mooney M R, Mooney J F, Van Tassel R A. et al .
The Nimbus Hemopump: a new left ventricular assist device that combines myocardial protection with circulatory support.
J Invasive Cardiol.
1990;
2
169-173
-
12
Smalling R W.
Transvalvular left ventricular assistance in acute myocardial infarction with cardiogenic shock and high risk angioplasty: experimental and clinical results with the Hemopump.
J Interv Cardiol.
1995;
8
265-273
-
13
Jaski B E, Lingle R J, Overlie P. et al .
Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse.
Asaio J.
1999;
45
615-618
-
14
Figulla H R.
Circulatory support devices in clinical cardiology. Current concepts.
Cardiology.
1994;
84
149-155
-
15
Hypothermia after Cardiac Arrest Study Group .
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
N Engl J Med.
2002;
346
549-556
-
16
Mehlhorn U, Brieske M, Gutsch E. et al .
LIFEBRIDGE: a portable, modular, rapidly available "plug-and-play" mechanical circulatory support system.
Ann Thorac Surg.
2005;
79
in press
-
17
Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen H A, Schuler G.
Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance.
Circulation.
2001;
104
2917-2922
-
18
Vogel R A, Shawl F, Tommaso C. et al .
Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty.
J Am Coll Cardiol.
1990;
15
23-29
-
19
Hochman J S, Sleeper L A, Webb J G. et al .
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
N Engl J Med.
1999;
341
625-634
-
20
Ferrari M, Wittmann G, Neumann S, Panzer W, Figulla H R.
Die perkutan implantierbare Herz-Lungen-Maschine erweitert die therapeutischen und diagnostischen Möglichkeiten bei therapierefraktärem Kreislaufstillstand - Fallpräsentation und Übersicht.
Intensivmed Notfallmed.
1998;
35
56-61
-
21
Mori Y, Ueno K, Hattori A. et al .
Emergency cardiopulmonary bypass support in patients with cardiac arrest caused by myocardial infarction.
Artif Organs.
1994;
18
698-701
PD Dr. med. Dr. Disc. pol. M. Ferrari
Klinik für Innere Medizin I · Friedrich-Schiller-Universität
Erlanger Allee 101 · 07740 Jena
Phone: 0 36 41/9 32 45 27
Fax: 0 36 41/9 32 41 02
Email: markus.ferrari@med.uni-jena.de